Episodes of gastrointestinal bleeding, stomach ulcers, easy bruising, allergic reactions, and drug interactions, etc. occurred. Enthusiasm waned. Patients on lower dose aspirin had fewer adverse ...
Scientists’ reaction to the study was mixed and they warned it is not a miracle cure. Professor Ruth Langley, from University College London, is leading a trial of aspirin on human cancer patients.